Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status.
Wendy FangRachel KennyQurat-Ul-Ain RizviLawrence P McMahonMayur GargPublished in: BMC gastroenterology (2020)
Hypophosphataemia following FCM is common, unrelated to symptomatic adverse events, baseline intestinal or systemic inflammation, or vitamin D status.